Ten-Year All-Cause Mortality Following Staged Percutaneous Revascularization in Patients With Complex Coronary Artery Disease.

Author(s): Garg, S. et al. 
Source: Cardiovascular Revascularization Medicine : including molecular interventions 2022 May; Vol. 38, pp. 124-126. 
Abstract: Medical and/or economic reasons sometimes necessitate the staging of percutaneous coronary intervention (SPCI) procedures in patients with complex coronary artery disease; however, the impact of this on very long-term outcomes is unknown. The aim of the present study is to assess 10-year all-cause mortality in patients with the three-vessel disease (3VD) and/or left main disease (LM) undergoing SPCI.

• Request full text access here